Cancer: Who Lives? Who dies? | Ted Goldstein Ph.D. | TEDxSanFrancisco
Ted Goldstein is a Silicon Valley tech executive turned cancer researcher. After a successful career and an instrumental role as top executive at Apple, Ted ...
TEDx Talks
National Cancer Center Hospital Department of Experimental Therapeutics
National Cancer Center Hospital Department of Experimental Therapeutics https://phase1-oncol.ncc.go.jp □Japanese version https://youtu.be/rIS_29ZJYtI.
国立がん研究センター公式チャンネル
Rewriting the Genetic Code: A Cancer Cure In the Making | Tal Zaks | TEDxBeaconStreet
The War on Cancer has been raging for over a century, and Tal Zaks may have the biggest breakthrough yet. His idea, to go straight to the source of the problem ...
TEDx Talks
Immunotherapy vs. targeted therapy for cancer treatment
In this episode, Dr. David Hong explains how immunotherapy and targeted therapy work, how they are different and areas where the two overlap. Request an ...
MD Anderson Cancer Center
Organizer Interview: Cancer Stem Cells: Advances in Biology and Clinical Translation
Cancer Stem Cells: Advances in Biology and Clinical Translation (T2) Scientific Organizers: Irene Oi Lin Ng, Xin Wei Wang & Dean G. Tang October 13—17, ...
KeystoneSymposia
A Preview of ASCO 2021; a Moble App to help Prove a Traveler Health Status after Receiving the COVID
With the start of the 2021 annual meeting of the American Society of Clinical Oncology (ASCO), Physician's Weekly shares a preview of some of the interesting ...
Onco'Zine - The International Oncology Network
Experimental Immunotherapy - Dr. Steve Dow, Flint Animal Cancer Center
Dr. Steve Dow's Experimental Immunotherapy research program investigates tumor immune responses and develops new cancer immunotherapies.
Flint Animal Cancer Center
What are Clinical Trials?
Do you know what a clinical trial is? A clinical trial is a research study that is conducted using patient volunteers to find safe and effective treatments for a variety ...
Penn Medicine
Mohit Jolly (Rice U.): Circulating tumor cell cluster: A model for cancer metastasis
Despite major advances in cancer biology, we do not fully understand the molecular cues that trigger metastasis. Cancer cells need to leave behind the organ of ...
iBiology
Cancer Stem Cells with Sandra Dillon, Tannishtha Reya, Rob Signer, and Karen Aboody
03:52 - Cancer Stem Cells: A Patient's Perspective - Sandra Dillon, 09:55 - Targeting Stem Cell Signals in Cancer Progression and Therapy Resistance ...
University of California Television (UCTV)
Experimental Glioblastoma Vaccine Shows Promise in Slowing Brain Tumor Growth
In clinical trials, 97% of patients receiving a new glioblastoma vaccine did not experience tumor progression in the six months following treatment. Learn more ...
Cleveland Clinic
Gene Editing - from experimental to clinical trials
Speaker: Matthew Porteus, Stanford University Chair: Hildegard Büning, Hannover Medical School.
European Society for Gene and Cell Therapy
Bioinformatics for Precision Oncology - the intersection of Cancer Research and Medical Applications
This online training program is for students with a background in cell and molecular biology or bioinformatics and an interest in oncology. In the training sessions ...
Pine Biotech
Why is it so hard to cure cancer? - Kyuson Yun
We've harnessed electricity, sequenced the human genome, and eradicated smallpox. But after billions of dollars in research, we haven't found a solution for a ...
TED-Ed
The Translational Relevance of Experimental Models in Cancer Immunotherapy
Cancers that are able to successfully grow are the ones that have evolved mechanisms to escape the immune system. Immunotherapeutic strategies, such as ...
Cell Press
New Thyroid Cancer Drug
For information on thyroid cancer treatment advancements, visit ...
MD Anderson Cancer Center
Couple raises money for experimental brain cancer treatment
A Manitoba woman wanted to undergo the NeuroBlate brain cancer treatment in Vancouver, but found the B.C. government would not fund it. Welcome to The ...
CBC News: The National
Leiomyosarcoma: Personalized Sarcoma Therapy - Fritz C. Eilber, MD | UCLA Cancer Care
Dr. Fritz C. Eilber talks about the the history of sarcoma and Leiomyosarcoma treatment at UCLA. Dr. Eliber is Director of the UCLA Sarcoma ...
UCLA Health
Experimental cancer therapy shown to dramatically prolong life
Duke University released a study Wednesday detailing the results of an experimental treatment aimed at getting a patient's immune system to fight off ...
CBS Evening News
JFK Medical Center: Experimental Gene Therapy for Brain Tumors
CBS 2 News television spot about a new cutting-edge, experimental therapy that uses a combination treatment of an old drug and a virus that acts like a 'guided ...
JFK Medical Center
Talking to Your Oncologist about Cancer Immunotherapy
When do most patients first learn about immunotherapy? How long can you start after your initial course of treatment? How does it feel to take part in a clinical ...
Cancer Research Institute
A new approach to prostate cancer treatment?
A clinical trial is testing whether targeting treatments to a genetic anomaly can lead to more targeted treatment for prostate cancer. Learn more about this phase ...
Michigan Medicine
What does “randomized”, “standard of care arm” and “experimental arm” mean in a clinical trial?
Physicians explain what randomization, standard of care arm and experimental arm mean in clinical trial study design. Randomization is where participants are ...
ThePancreasPatient
Oncomine® applications for cancer research
Exploring the Oncomine® Platform and applications for cancer research. The Oncomine® Platform contains an extensive collection of curated gene expression, ...
Thermo Fisher Scientific
Cancer Immunotherapy 101 with Dr. E. John Wherry
Dr. E John Wherry, director of the UPenn Institute for Immunology, explains how our immune system works, breaks down the complex science underlying ...
Cancer Research Institute
Experimental oncolytic immunotherapy for treatment of cancer patients incurable w routine approaches
"Experimental oncolytic immunotherapy for individualized treatment of cancer patients incurable with routine approaches" Talk by Professor Akseli Hemminki, ...
Nordic Committee on Bioethics
Understanding Glioblastoma Brain Cancer
Glioblastoma is the most common type of brain cancer but often misdiagnosed. Oncologist Matthias Holdhoff describes glioblastoma, how it's treated and clinical ...
Johns Hopkins Medicine
Using Dendritic Cells to Create Cancer Vaccines
November 13, 2007 presentation by Edgar Engleman for the Stanford School of Medicine Medcast lecture series. Edgar Engleman, MD, medical director of the ...
Stanford
A Day in the Life | Memorial Sloan Kettering Cancer Center
At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing ...
Memorial Sloan Kettering Careers
Keynote Presentation: It is Time for TIME (Tumor Immune Microenvironment) in Experimental and...
Presented By: Alexander David Borowsky, MD Speaker Biography: Dr. Borowsky is a surgical and molecular pathologist with expertise in cancer diagnostics ...
LabRoots
Immunotherapy and Clinical Trials for Brain Tumors - Linda Liau, MD, PhD, MBA | UCLA Neurosurgery
Dr. Linda Liau presents Immunotherapy and Clinical Trials for Brain Tumors at the UCLA Neurosurgery Update 2019 on March 1-2, 2019. UCLA Neurosurgery ...
UCLA Health
Experimental treatment uses modified stem cells to fight cancer | Mission Ahead
Daniel Apodaca is a 25-year-old film student at UCLA. He's also the first patient in a clinical trial that's testing a treatment using genetically modified bone ...
CNN Business
Which Cancers Can Be Treated With Immunotherapy? Ask a Scientist
There is no reason why you can't treat any cancer with immunotherapy. All cancers have mutations. If the mutation can be seen, an immune response can ...
Cancer Research Institute
Child with rare cancer is first to receive NC State scientist's experimental treatment
Child with rare cancer is first to receive NC State scientist's experimental treatment.
CBS 17
A New Norm for Skin Cancer Patients: Dale’s Immunotherapy Story
After Dale exhausted several treatment options for cutaneous squamous cell carcinoma, he enrolled in a clinical trial testing a PD-1 blocking antibody called ...
Cancer Research Institute
PCF Salons: The Science Behind Regeneron’s Experimental Antibody Treatment
If you're curious about the COVID19 treatment that President Trump is taking, here's an explanation from one of the innovators of this work, during our Hamptons ...
Prostate Cancer Foundation
Can we eat to starve cancer? - William Li
William Li presents a new way to think about treating cancer and other diseases: anti-angiogenesis, preventing the growth of blood vessels that feed a tumor.
TED-Ed
Fighting Glioblastoma with an Experimental Therapy: Stratton’s Story
After being diagnosed with glioblastoma, an aggressive brain tumor, Stratton Muhmel refused to give up. He enrolled in an experimental new treatment that ...
Houston Methodist
Volunteers sought: People with HPV-positive tonsil and tongue cancers
Mayo Clinic in Rochester, Minn., is seeking volunteers for a clinical trial for patients with human papillomavirus (HPV) positive tonsil or tongue (oropharynx) ...
Mayo Clinic
Breast cancer, identified protein active in the process of metastasis.
Listed on "Science Signaling" European research, led by the Department of Experimental and Clinical Medicine, University of Florence, which identified a ...
Università degli Studi di Firenze
Clinical Trials = Different Phases of Clinical Trial (HINDI) By Solution Pharmacy
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioural research studies on human participants are ...
Solution- Pharmacy
Advances in mRNA Vaccine Therapies in Infectious Diseases Dr. Justin Richner
Nanomedicine Innovation Network Justin M. Richner, PhD Assistant Professor Department of Microbiology & Immunology University of Illinois Chicago.
PrecisionNanoSystems
![Cancer (Experimental and clinical) : Section XVI [of] Experta medica. Vol.119, №4](https://static.rusist.info/screens/003/295/287.jpg)
